Aidsmap

For patients with HIV viral load is key in immune response to yellow fever vaccine

Thu, 02/02/2012 - 08:10
Viral load is the only factor associated with a poorer antibody response to the yellow fever vaccine in patients with HIV, according to a French study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. For patients vaccinated after diagnosis with HIV, an undetectable viral load was the “unique determinant” of
Categories: frontpage

Contraception in HIV prevention trials: injectable hormonal methods more effective?

Thu, 02/02/2012 - 07:10
Women using injectable (hormonal) contraceptives had a significantly lower rate of pregnancy compared to those using oral contraception in a major HIV prevention study, researchers report in the advance online edition of AIDS. However, the same study also found that women who used an injectable hormonal contraceptive method were at higher risk of
Categories: frontpage

Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggests

Wed, 01/02/2012 - 11:30
Men who have sex with men may now be at considerably higher risk of acquiring HIV than other at-risk groups such as female sex workers or young people of either sex, if findings by the International AIDS Vaccine Initiative (IAVI) of HIV incidence at two centres in Kenya can be generalised to other populations. The
Categories: frontpage

HIV care providers in US struggling to cope with rising patient numbers

Wed, 01/02/2012 - 08:40
HIV doctors in the US are struggling to meet the demands of a rising patient caseload, according to the findings of a national survey. Two-thirds of HIV treatment providers reported an increase in patient numbers, and a third reported difficulties being reimbursed for the care they provided. The second annual HealthHIV State of Primary
Categories: frontpage

Quarter of men resume sex before wounds from circumcision fully healed in Zambian study

Tue, 31/01/2012 - 09:00
Approximately a quarter of men undergoing circumcision resume sexual activity before their wounds have fully healed, Zambian research published in the online edition of AIDS shows. Most of the men reporting the early resumption of sexual activity engaged in unprotected sex, often with multiple partners. The investigators calculated that early resumption of sexual activity at this
Categories: frontpage

Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use

Tue, 31/01/2012 - 08:10
Raltegravir could have a “useful” role in HIV post-exposure prophylaxis, according to investigators from the US writing in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Doctors in Boston, Massachusetts, prescribed a post-exposure prophylaxis (PEP) regimen of raltegravir (Isentress) with tenofovir and FTC (Truvada) to 100 patients after possible sexual exposure to HIV.
Categories: frontpage

For study participants, PrEP was an opportunity to save their relationship

Mon, 30/01/2012 - 10:00
Seeking to understand why adherence to pre-exposure prophylaxis (PrEP) was extremely high in a study of serodiscordant couples, qualitative researchers have found that trial participants saw PrEP as a way they could preserve their relationship despite the pressures created by the knowledge of different HIV status and the risk of infection. In an article published
Categories: frontpage

Majority of HIV-positive patients in US not receiving regular medical care

Mon, 30/01/2012 - 08:10
Only 45% of HIV-positive patients in the US are receiving regular medical monitoring, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests. The study also showed that a third of patients were not being linked with specialist HIV care within the first year of their diagnosis with the
Categories: frontpage

Hormonal contraception and HIV risk: no increased risk in South African cohort

Thu, 26/01/2012 - 14:10
During a study of 5567 South African women, looking at the effect of hormonal contraception on HIV acquisition, 270 women became HIV-infected. The researchers report that use of hormonal contraception did not increase the risk, overall, of becoming HIV positive, compared to non-hormonal contraception, in the advance online edition of AIDS. There
Categories: frontpage

Hormonal contraception and HIV risk: no increased risk in South African cohort

Thu, 26/01/2012 - 14:10
Of the 270 South African women from a cohort of 5567 who became HIV-infected, use of hormonal contraception did not increase their risk, overall, of getting HIV compared to non-hormonal contraception, researchers report in the advance online edition of AIDS. There was a modest but non-significant trend towards an increased risk of getting
Categories: frontpage

Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low

Wed, 25/01/2012 - 15:30
The performance of OraQuick, a widely used rapid point-of-care test for HIV diagnosis, is slightly poorer when testing oral fluid samples than when testing blood samples, according to a meta-analysis published in the online edition of Lancet Infectious Diseases this week.The authors also found that if the test is used in low-prevalence settings with oral
Categories: frontpage

Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low

Wed, 25/01/2012 - 15:30
The performance of OraQuick, a widely used rapid point-of-care test for HIV diagnosis, is slightly poorer when testing oral fluid samples than when testing blood samples, according to a meta-analysis, published in the online edition of Lancet Infectious Diseases this week.The authors also found that if the test is used in low prevalence settings with
Categories: frontpage

Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir

Wed, 25/01/2012 - 15:00
Vitamin D supplementation is associated with an improvement in a key marker of bone health in HIV-positive young adults treated with tenofovir, US research published in Clinical Infectious Diseases shows. Treatment with vitamin D3 lead to a significant fall in parathyroid hormone levels, an important regulator of calcium which has a significant role in bone metabolism.
Categories: frontpage

Smoking cessation counselling and treatment during routine HIV care helps patients to quit

Tue, 24/01/2012 - 10:30
The provision of smoking cessation counselling and therapy during routine HIV care increases the chances that patients will quit smoking and stay stopped, according to Swiss research published in HIV Medicine. Physicians at the Zurich HIV clinic received training about smoking cessation counselling and the use of medication to help those wanting to quit. Compared to
Categories: frontpage

English public health indicators to include late HIV diagnosis

Tue, 24/01/2012 - 09:30
The Department of Health this week announced the 66 ‘indicators’ with which the performance of the new public health system will be measured. To the relief of HIV campaigners, these include a measure of late HIV diagnosis. From 2013, management of the public health system in England will move from NHS primary care trusts to
Categories: frontpage

English public health indicators to include late HIV diagnosis

Tue, 24/01/2012 - 09:30
The Department of Health this week announced the 66 ‘indicators’ with which the performance of the new public health system will be measured. To the relief of HIV campaigners, these include a measure of late HIV diagnosis. From 2013, management of the public health system in England will move from NHS primary care trusts to
Categories: frontpage

Studies from US and Spain show that hepatitis vaccination programmes not reaching target populations

Mon, 23/01/2012 - 09:00
The majority of US adults at risk of hepatitis B remain unvaccinated against this potentially life-threatening infection, according to research published in advance of print in the online edition of Infection. The research highlighted missed opportunities for vaccination, especially for individuals who had received health care while in prison. The authors express concern that vaccination
Categories: frontpage

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

Fri, 20/01/2012 - 16:40
In a bid to reduce the risk of nevirapine resistance after the use of single-dose nevirapine to prevent mother-to-child HIV transmission, several research groups are now experimenting with the use of drugs that can speed up the clearance of nevirapine from the mother’s bloodstream after giving birth. For example, adding single dose-carbamazepine, a cheap, readily available anti-convulsant
Categories: frontpage

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

Fri, 20/01/2012 - 16:40
In a bid to reduce the risk of nevirapine resistance after the use of single-dose nevirapine to prevent mother-to-child HIV transmission, several research groups are now experimenting with the use of drugs that can speed up the clearance of nevirapine from the mother’s bloodstream after giving birth. For example, adding single dose-carbamazepine, a cheap, readily available anti-convulsant
Categories: frontpage

Common side-effects of hepatitis C protease inhibitors: clinical management advice published

Fri, 20/01/2012 - 15:30
The addition of the protease inhibitors telaprevir or boceprevir to hepatitis C treatment regimens increases the risk of anaemia, according to a review article published in Liver International. The author also found that telaprevir treatment was associated with an increased risk of rash and itching as well as some anorectal symptoms. However, these side-effects were
Categories: frontpage